ADT	Androgen deprivation therapy
ARPI	Androgen Receptor Pathway Inhibitor
CRPC	Castrate-resistant prostate cancer
CSS	Cancer-specific survival
ENRT	Elective nodal irradiation
FFS	Failure-free survival
GU	Genitourinary
HMB	High metastatic burden
HSPC	Hormone-sensitive prostate cancer
LC	Local control
LHRHa	Luteinizing hormone-releasing hormone analog
LMB	Low metastatic burden
MDT	Metastasis-directed therapy
MPC	Metastatic prostate cancer
OMPC	Oligo-metastatic prostate cancer
OS	Overall survival
PET	Positron emission tomography
PFS	Progression-free survival
PSA	Prostate-specific antigen
PSMA	Prostate-specific membrane antigen
QoL	Quality of life
RP	Radical Prostatectomy
RT	Radiation Therapy
SBRT	Stereotactic-body radiation therapy
SOC	Standard of care